Abstract
A new extended release formula of trazodone oral tablets is available in the Czech Republic since 2015. It is intended for the treatment of depression of various etiology.
It has beneficial effect in cases with comorbid anxiety and insomnia. The maximum potential of the full trazodone dose can be employed in such group of patients.
Those could be treated by trazodone monotherapy without the necessity of using additional anxiolytic and hypnotic medication. Here presented case report depicts the full trazodone dose utilization as a first line treatment of depressive disorder.
Application of the prolonged release trazodone form led to a fast anxiety and insomnia disappearance. It also enabled to stop the hypnotic and anxiolytic comedication.